Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-019334

Exec. VP Chief Legal Officer sold 2,444 shares at $15.82 ($38,664)

  • Exec. VP Chief Legal Officer acquired 2,444 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stark David Matthew · Exec. VP Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-12 Exercise or conversion : show line 1 in the form +2,444 5,418.39 D
2019-03-12 Sale : show line 2 in the form −2,444 $15.82 $38,664 2,974.39 D
Open-market sales · 2,444 sh · avg $15.82 · $38,664

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-12 Exercise or conversion : show line 3 in the form Restricted Share Units −2,444 0 D
Loading xslF345X03/doc4.xml…